The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serezani, C. H.
Right arrow Articles by Jancar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serezani, C. H.
Right arrow Articles by Jancar, S.
The Journal of Immunology, 2006, 177: 3201-3208.
Copyright © 2006 by The American Association of Immunologists, Inc.

Leukotrienes Are Essential for the Control of Leishmania amazonensis Infection and Contribute to Strain Variation in Susceptibility1

Carlos H. Serezani2,*,{dagger}, Joao H. Perrela*, Momtchilo Russo*, Marc Peters-Golden{dagger} and Sonia Jancar*

* Department of Immunology, Institute of Biomedical Science IV, University of São Paulo, São Paulo, Brazil; and {dagger} Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109

Leukotrienes (LTs) are known to be produced by macrophages when challenged with Leishmania, but it is not known whether these lipid mediators play a role in host defense against this important protozoan parasite. In this study, we investigated the involvement of LTs in the in vitro and in vivo response to Leishmania amazonensis infection in susceptible (BALB/c) and resistant (C3H/HePAS) mice. Pharmacologic or genetic deficiency of LTs resulted in impaired leishmanicidal activity of peritoneal macrophages in vitro. In contrast, addition of LTB4 increased leishmanicidal activity and this effect was dependent on the BLT1 receptor. LTB4 augmented NO production in response to L. amazonensis challenge, and studies with a NO synthesis inhibitor revealed that NO was critical for the enhancement of macrophage leishmanicidal activity. Interestingly, macrophages from resistant mice produced higher levels of LTB4 upon L. amazonensis challenge than did those from susceptible mice. In vivo infection severity, as assessed by footpad swelling following s.c. promastigote inoculation, was increased when endogenous LT synthesis was abrogated either pharmacologically or genetically. Taken together, these results for the first time reveal an important role for LTB4 in the protective response to L. amazonensis, identify relevant leishmanicidal mechanisms, and suggest that genetic variation in LTB4 synthesis might influence resistance and susceptibility patterns to infection.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Fundação de Amparo a Pesquisa do Estado de São Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brazil); and National Institutes of Health HL HL-058897.

2 Address correspondence and reprint requests to Dr. Carlos Henrique Serezani, University of Michigan Health System, 6301 Medical Science Research Building III, Box 0642, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0642. E-mail address: cserezan{at}med.umich.edu

3 Abbreviations used in this paper: LT, leukotriene; 5-LO, 5-lipoxygenase; FLAP, 5-LO-activating protein; cysLT, cysteinyl LT; iNOS, inducible NO synthase; KO, knockout; WT, wild type.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.